Trial 9L-11-8


HLA-Mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High-Risk Acute Myeloid Leukemia.

Type: Treatment
Phase: Phase I
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic, Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Ann Mohrbacher, M.D.
Other Trial Staff:  Christine Duran, Coordinator, Christine Duran, D.M., Ibrahim Syed, D.M., Ibrahim Syed, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.